{"title": "KEGG DRUG: COVID-19 vaccine (Ad26.COV2-S [recombinant])", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": null, "cleaned_text": "Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] J ANTIINFECTIVES FOR SYSTEMIC USE J07 VACCINES J07B VIRAL VACCINES J07BN Covid-19 vaccines J07BN02 vector, non-replicating D12129 COVID-19 vaccine (Ad26.COV2-S [recombinant]) <JP> Therapeutic category of drugs in Japan [BR:br08301] 6 Agents against pathologic organisms and parasites 63 Biological preparations 631 Vaccines 6313 Viral vaccines D12129 COVID-19 vaccine (Ad26.COV2-S [recombinant]) Drug groups Antiviral DG03172 COVID-19 vaccine D12129 COVID-19 vaccine (Ad26.COV2-S [recombinant]) New drug approvals in the USA [br08319.html] New molecular entities and new therapeutic biological products D12129 New drug approvals in Europe [br08329.html] European public assessment reports (EPAR) authorised medicine D12129 New drug approvals in Japan [br08318.html] Drugs with new active ingredients D12129 New drug approvals in the USA, Europe and Japan [br08328.html] Approval dates by FDA, "}